| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39d2459e45e5dd33a6778479dca2d065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10f7a8663a73eb5fd30983e5ea3a3642
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_847a3f4b16c3b3a74c782d9ba08b0987 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 |
| filingDate |
2010-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_338eeba65a0c77e5ec082ac47dc95b65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3cdadef40724e4250839eef2596c969
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e838efb55e2d866d3be05c02c2da26f7 |
| publicationDate |
2013-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8557860-B2 |
| titleOfInvention |
Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| abstract |
A compound comprising n n n n n n n n n n or a pharmaceutically acceptable salt or a prodrug thereof, n having the groups described in detail herein is disclosed. n n n Also disclosed herein are compounds comprising n n n n n n n n n n or derivatives thereof, or pharmaceutically acceptable salts, tetrazoles, or prodrugs of compounds of the structure or derivatives thereof, said derivatives being described in detail herein. n n n Also disclosed herein are methods of treating diseases or conditions, including glaucoma and elevated intraocular pressure. Compositions and methods of manufacturing medicaments related thereto are also disclosed. |
| priorityDate |
2004-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |